|
|
|||||||||||
1 Consultant Psychiatrist, St. James's Hospital, Leeds, 9
2 Senior Registrar, St. James's Hospital, Leeds, 9
No statistically significant difference in outcome was found as a result of treatment with either drug, although there is the suggestion that amitriptyline might be more effective in the treatment of reactive depressive illness. Both drugs were highly potent in reducing the depressive score ratings within their respective samples, and in view of this and previous experience with amitriptyline both should be considered as valuable anti-depressive preparations in clinical practice. No particular difference in the incidence of side-effects could be detected in the sampling used.
Submitted on September 25, 1966
This article has been cited by other articles:
![]() |
C. BARBUI and M. HOTOPF Amitriptyline v. the rest: still the leading antidepressant after 40 years of randomised controlled trials The British Journal of Psychiatry, February 1, 2001; 178(2): 129 - 144. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. E. Ziegler, P. J. Clayton, and J. T. Biggs A Comparison Study of Amitriptyline and Nortriptyline With Plasma Levels Arch Gen Psychiatry, May 1, 1977; 34(5): 607 - 612. [Abstract] [PDF] |
||||
![]() |
J. B. Morris and A. T. Beck The Efficacy of Antidepressant Drugs: A Review of Research (1958 to 1972) Arch Gen Psychiatry, May 1, 1974; 30(5): 667 - 674. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |